Pfizer Partners with Aimedis Healthcare to Explore Blockchain For Pharmaceuticals
The blockchain is becoming an excellent resource for many companies, including those in the pharmaceutical industry. Most recently, Pfizer Deutschland GmbH, the German-pharmaceutical giant, has started looking into the blockchain as well. To date, the blockchain has spurred over 86,000 new projects and 27,000 of them have been in this past year.
Pfizer’s interest arose when it formed a partnership with Aimeds, a healthcare startup. Together, the companies are looking into using the blockchain and artificial intelligence to identify proof of work, medical services, and to innovate the healthcare field.
Generally, blockchain has positively influenced the healthcare field in several ways. Two companies in particular, Patientory and Coral Health, have adopted the technology. The former is using the technology to generate patient profiles, tracking doctor appointments, insurance paperwork, medical bills, and more. The latter uses the technology to provide patients with the full control concerning information that they share and ensuring the best possible treatment for their health conditions.
Additionally, medical professionals will be able to treat patients using advanced monitoring systems rather than in an office. The purpose of the technology is to ensure that patients can receive better care and that medical professionals are able to provide it as well.